State Street Corp Gossamer Bio, Inc. Transaction History

State Street Corp

  • $2.36 Trillion
  • Q1 2025

A detailed history of State Street Corp transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 882,676 shares of GOSS stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
882,676
Previous 768,476 14.86%
Holding current value
$1.09 Million
Previous $691,000 40.38%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$0.85 - $1.53 $97,070 - $174,726
114,200 Added 14.86%
882,676 $970,000
Q4 2024

Feb 14, 2025
BUY
$0.66 - $1.07 $36,762 - $59,599
55,700 Added 7.81%
768,476 $691,000
Q2 2024

Aug 14, 2024
BUY
$0.51 - $1.27 $11,997 - $29,876
23,525 Added 3.41%
712,776 $641,000
Q1 2024

May 15, 2024
SELL
$0.8 - $1.51 $19,440 - $36,693
-24,300 Reduced 3.41%
689,251 $813,000
Q4 2023

Feb 14, 2024
BUY
$0.48 - $1.08 $184,032 - $414,072
383,400 Added 116.13%
713,551 $649,000
Q3 2023

Nov 14, 2023
SELL
$0.78 - $1.82 $11,388 - $26,572
-14,600 Reduced 4.23%
330,151 $274,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $959,171 - $1.5 Million
-978,746 Reduced 73.95%
344,751 $413,000
Q1 2023

May 15, 2023
SELL
$0.96 - $2.92 $25.5 Million - $77.4 Million
-26,520,488 Reduced 95.25%
1,323,497 $1.67 Million
Q4 2022

Feb 14, 2023
BUY
$1.74 - $12.87 $41.9 Million - $310 Million
24,066,082 Added 637.02%
27,843,985 $60.4 Million
Q3 2022

Nov 15, 2022
SELL
$7.21 - $14.88 $701,468 - $1.45 Million
-97,291 Reduced 2.51%
3,777,903 $45.3 Million
Q2 2022

Aug 15, 2022
BUY
$5.97 - $9.97 $3.39 Million - $5.66 Million
567,264 Added 17.15%
3,875,194 $32.4 Million
Q1 2022

May 16, 2022
BUY
$8.44 - $12.49 $133,681 - $197,829
15,839 Added 0.48%
3,307,930 $28.7 Million
Q4 2021

Feb 14, 2022
BUY
$10.12 - $14.07 $6.37 Million - $8.85 Million
629,325 Added 23.63%
3,292,091 $37.2 Million
Q3 2021

Nov 15, 2021
SELL
$7.25 - $13.23 $4.82 Million - $8.8 Million
-664,950 Reduced 19.98%
2,662,766 $33.5 Million
Q2 2021

Aug 16, 2021
SELL
$8.0 - $9.75 $4.3 Million - $5.25 Million
-537,965 Reduced 13.92%
3,327,716 $27 Million
Q1 2021

May 17, 2021
BUY
$8.63 - $10.94 $9.79 Million - $12.4 Million
1,134,827 Added 41.56%
3,865,681 $35.8 Million
Q4 2020

Feb 16, 2021
BUY
$8.3 - $13.59 $4.78 Million - $7.83 Million
575,865 Added 26.72%
2,730,854 $26.4 Million
Q3 2020

Nov 10, 2020
BUY
$11.3 - $14.75 $2.87 Million - $3.75 Million
254,417 Added 13.39%
2,154,989 $26.7 Million
Q2 2020

Aug 14, 2020
BUY
$9.52 - $15.98 $2.3 Million - $3.86 Million
241,674 Added 14.57%
1,900,572 $24.7 Million
Q1 2020

May 11, 2020
BUY
$8.0 - $15.48 $13.3 Million - $25.7 Million
1,658,898 New
1,658,898 $16.8 Million

Others Institutions Holding GOSS

# of Institutions
127
Shares Held
162M
Call Options Held
2.11M
Put Options Held
57.8K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $117M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email